Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...

The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

Prostate cancer is usually treated with surgery and radiation therapy, but these can have drastic side effects. A new ...

Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) s ...

Urination problems affect millions of men worldwide, often developing so gradually that many dismiss early warning signs.

Medical experts emphasize that regular prostate screenings, particularly through rectal examinations, remain one of the most ...

After men turn 40, it is crucial for them to be regular with their health check-ups, especially when they experience trouble ...

Matthew R. Zibelman, MD, discusses treatment options in muscle-invasive, perioperative, and metastatic bladder cancer.

While cryotherapy can be effective, it’s not the right treatment for everybody so it’s good for you to know what it entails.

Francis Medical has obtained $80 million in venture capital funding to support the development of its water vapor ablation ...

The Food and Drug Administration (FDA) has approved Gemtesa ® (vibegron) for the treatment of overactive bladder (OAB ... is an important milestone for the men with unresolved symptoms of ...